Innovative Eyewear (NASDAQ: LUCYW) raises ATM share limit in new filing

Rhea-AI Filing Summary

Innovative Eyewear, Inc. reported that on August 15, 2025 it filed a prospectus supplement to increase the maximum number of shares of its common stock that may be issued under its existing At The Market Offering Agreement with H.C. Wainwright & Co., originally dated April 15, 2024. This update means the company can issue more common shares through that ongoing at-the-market program as needed, rather than in a single large transaction.

The company also filed a legal opinion from Ellenoff Grossman & Schole LLP, attached as Exhibit 5.1, confirming the legality of issuing and selling these shares. A related consent from the same firm is included as Exhibit 23.1.

false 0001808377 0001808377 2025-08-15 2025-08-15 0001808377 lucy:CommonStockParValue0.00001PerShareMember 2025-08-15 2025-08-15 0001808377 lucy:WarrantsToPurchaseCommonStockMember 2025-08-15 2025-08-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 15, 2025

INNOVATIVE EYEWEAR, INC.

(Exact name of registrant as specified in its charter)

Florida		001-41392		85-0734861
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

11900 Biscayne Blvd., Suite 630 North Miami, Florida		33181
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (786) 785-5178

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.00001 per share		LUCY		The Nasdaq Stock Market LLC
Warrants to purchase Common Stock		LUCYW		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events.

On August 15,2025, Innovative Eyewear, Inc. (the “Company”) filed a prospectus supplement to increase the maximum number of shares (the “Shares”) of the Company’s common stock, par value $0.00001 per share, issuable pursuant to the At The Market Offering Agreement between the Company and H.C. Wainwright & Co., dated April 15, 2024.

Attached hereto as Exhibit 5.1 to this Current Report is the opinion of Ellenoff Grossman & Schole LLP relating to the legality of the issuance and sale of the Shares.

1

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

5.1		Opinion of Ellenoff Grossman & Schole LLP
23.1		Consent of Ellenoff Grossman & Schole LLP (included in Exhibit 5.1)
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: August 15, 2025

	INNOVATIVE EYEWEAR, INC.
	By:	/s/ Harrison Gross
	Name:	Harrison Gross
	Title:	Chief Executive Officer

3

FAQ

What did Innovative Eyewear (LUCYW) disclose in this 8-K?

Innovative Eyewear disclosed that it filed a prospectus supplement to increase the maximum number of common shares that can be issued under its existing At The Market Offering Agreement with H.C. Wainwright & Co. It also filed a legal opinion and related consent from Ellenoff Grossman & Schole LLP.

What is the purpose of Innovative Eyewears at-the-market offering update?

The update increases the maximum number of common stock shares the company may issue through its at-the-market program with H.C. Wainwright & Co., allowing it to raise equity capital over time by selling shares directly into the market.

Who is the sales agent for Innovative Eyewears at-the-market offering?

H.C. Wainwright & Co. acts as the companys counterparty under the At The Market Offering Agreement referenced in the filing, which was originally dated April 15, 2024.

What legal documents were filed with this Innovative Eyewear 8-K?

The company filed an opinion of Ellenoff Grossman & Schole LLP as Exhibit 5.1 regarding the legality of issuing and selling the shares, and a related consent from the same firm as Exhibit 23.1.

Does this Innovative Eyewear filing involve its listed warrants (LUCYW)?

The filing specifically addresses an increase in the maximum number of common stock shares issuable under the at-the-market agreement. The company also lists warrants to purchase common stock as a separate class on The Nasdaq Stock Market LLC, but the described action concerns common shares.